Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden (Q44256164)

1 December 2017

title

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden (English)

1 reference

1 December 2017

0 references

3

Jan Sundquist

1 reference

1 December 2017

2

Kristina Sundquist

1 reference

1 December 2017

Jianguang Ji

1

1 reference

1 December 2017

publication date

12 April 2012

1 reference

Lancet Oncology Commission

1 December 2017

published in

1 reference

1 December 2017

volume

13

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

642-648

1 reference

Polyglutamine disease and neuronal cell death.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Diseases of unstable repeat expansion: mechanisms and common principles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Polyglutamine diseases: emerging concepts in pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

1 reference

7 January 2021

Update on degenerative ataxias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Cancer and neurodegeneration: between the devil and the deep blue sea.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Trinucleotide repeat length instability and age of onset in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Monozygotic twins discordant for Huntington disease after 7 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Substance abuse may be a risk factor for earlier onset of Huntington disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

p53 and its mutants in tumor cell migration and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

The first 30 years of p53: growing ever more complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

What are the hallmarks of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

External review and validation of the Swedish national inpatient register

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970132-8

7 January 2021

10.1016/S1470-2045(12)70132-8

Identifiers

DOI

1 reference

1 December 2017

1 reference